Chromosomal translocations joining the immunoglobulin (IG) and MYC genes have been extensively reported in Burkitt's and non-Burkitt's lymphomas but data concerning MYC rearrangements with non-IG partners are scarce. In this study, 8q24 breakpoints from 17 B-cell lymphomas involving non-IG loci were mapped by fluorescence in situ hybridization (FISH). In seven cases the breakpoint was inside a small region encompassing MYC: in one t(7;8)(p12;q24) and two t(3;8)(q27;q24), it was telomeric to MYC whereas in four cases, one t(2;8)(p15;q24) and three t(8;9)(q24;p13) it was located in a 85 kb region encompassing MYC. In these seven cases, partner regions identified by FISH contained genes known to be involved in lymphomagenesis, namely BCL6, BCL11A, PAX5 and IKAROS. Breakpoints were cloned in two t(8;9)(q24;p13), 2.5 and 7 kb downstream from MYC and several hundred kb 5 0 to PAX5 on chromosome 9, joining MYC to ZCCHC7 and to ZBTB5 exon 2, two genes encoding zinc-finger proteins. In these seven cases, MYC expression measured by quantitative reverse transcription-polymerase chain reaction (RT-PCR) was significantly higher when compared to that of patients without 8q24 rearrangement (P ¼ 0.006). These results suggest that these rearrangements are the consequence of a non-random process targeting MYC together with non-IG genes involved in lymphocyte differentiation and lymphoma progression.
Introduction
The t(8;14)(q24;q32) translocation is the major primary rearrangement observed in Burkitt's lymphoma. Variant translocations, t(2;8)(p12;q24) and t(8;22)(q24;q11), are found in the remaining cases. 1 These translocations lead to a deregulated MYC expression as a consequence of the vicinity of transcriptional enhancers of the IG genes. The MYC gene product is a transcription factor, whose overexpression plays a key role in the pathogenesis of the disease. 2 Rearrangements of the 8q24 region with IG loci were also reported in other subtypes of nonHodgkin's lymphomas (NHL) and are postulated to be secondary events which could be associated with disease progression. [3] [4] [5] In a few number of cases, 8q24 rearrangements involving non-IG partner regions have been reported: a t(8;12)(q24;q22) in a transformed B-cell chronic lymphocytic leukaemia, 6 a t(8;9)(q24;p13) in two cases of diffuse large cell lymphomas 7 and a t(1;8)(p21;q24) in a cell line derived from a follicular lymphoma. 8 In this study, MYC rearrangements with non-IG partners were analysed by fluorescence in situ hybridization (FISH) in seventeen cases of lymphoma. In seven of these cases, the partner region was identified and molecular breakpoint characterization could be achieved in two t(8;9)(q24;p13) translocations. MYC expression was also studied in these seven cases.
Patients and methods

Patients
Seventeen patients were selected from the lymphoma database of the Centre Henri Becquerel. All had a B-cell lymphoma and a 8q24 rearrangement as detected by conventional cytogenetics, but neither t(8;14)(q24;q32), t(8;22)(q24;q11) nor t(2;8)(p11;q24). Tumours were classified according to the World Health Organization (WHO) classification. 9 The GCB and non-GCB phenotypes were defined using CD10, BCL6 and MUM1 immunostaining as described by Hans et al. 10 The International Prognostic Index (IPI) 11 was calculated for each patient and response to treatment was evaluated using Cheson criteria. 12 Clinical and cytogenetic data are summarized in Tables 1 and 2 , respectively. Of note, among eight patients bearing a t(14;18)(q32;q21), six had a diffuse large B-cell lymphoma (DLBCL) and one a Burkitt-like lymphoma (BLL) wheras only one patient had a follicular lymphoma (FL). None but one (case no. 3) of the DLBCL and BLL patients had a previous clinical history of FL. For real-time reverse rasncription-polymerase chain reaction (RT-PCR), cells of two additional groups of patients with B-cell lymphoma were studied as control, one without 8q24 rearrangement (24 samples), and one with a translocation involving MYC with IG light or heavy chains genes (13 samples), assessed by cytogenetics. The 24 samples from the first group were DLBCL.
Conventional cytogenetics and FISH analysis
Cytogenetic analysis was performed according to standard techniques. Slides were RHG-banded according to Sehested 13 and karyotypes were described according to the International System for Human Cytogenetic Nomenclature. 14 Chromosome walking with probe sets was used in combination with split-signal FISH. 15, 16 Estimation of breakpoint localization was performed assuming that split signals are efficiently detected only if a chromosome break is located at least 30 kb from the end of the BAC. FISH probes were prepared from bacterial artificial chromosomes (BAC) clones obtained from Bacpac Resources (CHORI, Oakland, CA, USA). Clone selection was made from the UCSC (release: may 2004) (http:// genome.ucsc.edu/) or Ensemble (http://www.ensembl.org/) databases. Probes genomic localization is shown in Figure 1 . The LSI BCL6 Dual Color break apart probe (Vysis, Downers Grove, IL, USA) was used as a first step to detect rearrangements of the 3q27 region. Genomic probes prepared from BAC clones with the Qiagen Large-Construct kit from Qiagen (Courtaboeuf, France) were labelled with Spectrum Orange or Green -dUTP (Vysis, Downers Grove, IL, USA) using a nick translation kit (Vysis) and hybridized according to the manufacturers recommendations. FISH analysis was performed on previously R-banded metaphases after three destaining steps in 50, 70 and 100% ethanol. Images were captured on a Zeiss Axioplan microscope with a CCD camera from Photometrics (Tucson, AZ, USA) and processed with Smart Capture (Vysis). Chromosomes were identified by conventional cytogenetics or by use of 1  660  M/45  PD  DLBCL  ABC  IV  222  3  Refractory  5  2  801  M/56  PD  DLBCL  GCB  IV  633  3  Refractory  1  3  877  F/69  Relapse  DLBCL  GCB  IV  342  4  CR  62  4  754  M/81  PD  DLBCL  GCB  IV  UK  -Death before treatment  0  5  541  F/80  PD  DLBCL  ABC  II  115  2  Refractory  6  6  602  M/53  PD  DLBCL  GCB  I  147  1  CR  114+  7  1168  F/56  PD  DLBCL  GCB  IV  646  3  CRu  26+  8  896  F/40  PD  DLBCL  ABC  IV  724  4  CR  27  9  616  M/71  PD  DLBCL  NA  IV  418  4  Refractory  1  10  288  M/69  PD  DLBCL  NA  III  144  2  Refractory  8 
Southern blot analysis
Southern blotting and hybridization analysis were carried out on genomic DNA from node biopsies as described previously.
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The myc-exon3 probe was a 1.4 kb ClaI-EcoRI fragment from MYC exon3 kindly provided by Dr T Fest, UPRES 2233-1247, Rennes, France. The myc-tel0 probe was prepared by cloning a 1.3 kb PCR product (primers: forward, TTTCCTGGTTCC CCTTATCC; reverse, ACTTTCCCCTTGACCATGAG) in a PGEM-T vector (Promega, Madison, USA). Probes location is depicted in Figure 3a .
LDI PCR and direct PCR
Long-distance inverse PCR (LDI-PCR), used to amplify unknown DNA sequences flanked on one side by an identified rearranged gene segment, was performed as described previously with some modifications. 18 One microgram of high molecular weight DNA was digested with 15 U suitable restriction enzyme overnight at 371C. 100 ng digested DNA was ligated overnight by 0.2 U of T4 DNA ligase (New England Biolabs, Ozyme, Saint Quentin-en-Yvelines, France) in a total volume of 125 ml at 161C. The first PCR reaction was performed with the Extensor Hi-Fidelity PCR Master Mix (ABgene, Courtaboeuf, France). Five microliters of ligation mixture were amplified in a 25 ml reaction with 12.5 ml of Master Mix and 0.75 ml of each 10 mM external RE and FE primers (see below). PCR conditions were as follow: Figure 1 Schematic representation of the genomic regions encompassing the MYC locus at 8q24 (a), the PAX5 locus at 9p13 (b), the BCL6 locus at 3q27 (c), the IKAROS locus at 7p12 (d), and the BCL11A locus at 2p15 (e). Genes, transcriptional units and MYC variant rearranging regions 45 are represented by grey boxes, and FISH probes by black boxes. Transcriptional orientation of genes is represented by horizontal arrows. Bold numbers indicate patients numbers and vertical arrows the approximate location of the breakpoints.
941C for 2 min; 10 cycles of 941C for 10 s, 581C for 45 sec, and 681C for 10 min, plus 20 cycles of 941C for 10 s, 581C for 45 s and 681C for 10-16 min and 20 s, that is, extension time increasing by 20 s at each cycle; 681C for 7 min. Nested PCR was performed on 1 ml of the first PCR product with internal RI and FI primers (see below) using the same PCR conditions. PCR products were analyzed by electrophoresis and bands were purified with the Qiaquick Gel Extraction kit from Qiagen and sequenced using the BigDye terminator Cycle Sequencing Kit (Applied Biosystems, Foster city, CA, USA) on an ABI 310 automated sequencer (Applied Biosystems). The external primers used were as follows: 1_FE, 5 0 -TTCAAAAGTATGTGCCTCATGG-3 0 were used to amplify breakpoint from der(8) and der(9) in case no. 1. 2der8_8, 5
0 -CCATTTGGAAGCAACAAAGG-3 0 and 2der8_9, 5 0 -CTGCACCTAGAGAGGGCATC-3 0 , 2der9_8, 5 0 -TACAGGG GCCCTTAGTGTGT-3 0 and 2der9_9, 5 0 -CACCCAGAAGCCT ATCTCGT-3 0 were used to amplify breakpoint from der(8) and der(9) in case no. 2.
Real-time RT-PCR for MYC
RNA purification and cDNA preparation were performed as previously described. 19 MYC expression was measured by realtime quantitative RT-PCR using the TaqMan technology on a ABI PRISM 7700 Sequence Detection System (Perkin-Elmer Applied Biosystems, Forster City, CA, USA). MYC primers and probe were designed as described by Latil et al. 20 Each sample was tested in duplicate and the expression level compared to that of the phorphobilinogen deaminase (PBGD) gene. 19 To take inter assay variations into account, relative amount of MYC was also compared to that of a patient without 8q24 rearrangement chosen as reference. Calculation of relative expression (RE) was performed as described previously. 20 Between-group overall comparison of RE was performed using the non-parametric Kruskal-Wallis ANOVA test with a 0.05 significance level. Two subsequent between-group comparisons were performed with the Mann-Whitney U-test with a 0.025 (0.05/2) significance level. Statistical analysis was carried out using NCSS software (NCSS Statistical Software, Kaysville, UT, USA).
Results
Analysis of 8q24 rearrangements
Results are summarized in Figure 1a . As for MYC translocations with IG genes, breakpoints were highly dispersed around MYC and all cases for which the 8q24 rearrangement could not be identified by cytogenetics, that is add(8q24), had a breakpoint located more than 1 Mb from MYC. The interstitial deletion from case no. 14 conserved the 2 Mb region encompassing MYC. A duplication of signals was observed with both RP11-89K10 and RP11-460A11 probes in cases no. 15-no. 17, thus indicating a cryptic duplication of the region encompassing the MYC locus but with limits beyond 1 Mb from MYC.
The seven remaining cases (no. 1-no. 7) had a breakpoint localized in a 430 kb cluster encompassing MYC. Breakpoints were close to MYC in cases no. 1-no. 4 for which the same probe CTD-3056O22 containing the MYC locus showed a split signal, allowing to localize the breakpoint in a 85 kb region encompassing MYC, but without any further information about its position relative to MYC. The breakpoint of case no. 5 was also close to MYC, but more telomeric: no BAC was shown to be splitted, but signals from neighbouring probes CTD-3056O22 (red) and CTD-2267H22 (green) were separated (Figure 2e) , thus indicating that the breakpoint was in the region covered by the neighbouring extremities of the probes. BAC probes used to define breakpoints in cases no. 6 and no. 7 were more telomeric, localized in the PVT1 and BVR1 variant rearranging regions. Examples of FISH results are given in Figures 2a-d, g, showing the red signal from the 8q24 probes localized on both derivative 8 and derivative partner chromosomes.
Analysis of 9p13 rearrangements from t(8;9)(q24;p13)
Three t(8;9)(q24;p13) translocations were studied by targeting the PAX5 region located at 9p13. Estimated breakpoints deduced from FISH data were clustered in a 330 kb region centromeric to PAX5 (Figure 1b) . In cases no. 1 and no. 2, separated signals were observed for BACs RP11-405L18 and RP11-397D12 (Figure 2a, b) indicating that breakpoints were distant from 420-520 and 270-400 kb from PAX5 (Figure 1b) . In case no. 3 breakpoint mapping was performed with the neighbouring probes RP11-397D12 and RP11-220I1 allowing to estimate the breakpoint location between 190 and 270 kb from PAX5 (Figure 1b ) and suggesting that it could be localized into the ZCCHC7 locus.
Analysis of 3q27 rearrangements from the t(3;8)(q27;q24)
We hypothesized that the BCL6 region could be involved in the t(3;8) translocations and then first used the commercial LSI BCL6 dual colour probe (Figure 1c) . In case no. 6, green and orange signals were separated, indicating a breakpoint occurring within the BCL6 locus. A split signal observed with the BCL6-containing RP11-211G3 probe confirmed this observation (Figure 2c) . In case no. 7, the signal from the telomeric part of the commercial probe was separated between chromosomes 3 and 8. Refinement of the localization of the breakpoint was performed using the RP11-44H4 probe (Figures 1c and 2d) indicating that the breakpoint was 90-200 kb telomeric to BCL6.
Analysis of 7p12 rearrangements from the t(7;8)(p12;q24)
Investigation of the 7p12 region was initiated by targeting the IKAROS region. As no signal from the IKAROS flanking probes RP11-95E2 and RP11-813K3 were found on derived chromosome 7, more centromeric probes were tested, distant from 0.5 to 1 Mb from IKAROS (Figure 1d) . A split signal was observed with the clone RP11-175C14 (Figure 2f) , showing that the breakpoint was located 1 Mb from IKAROS but only 100 kb from the COBL gene.
Analysis of 2p15 rearrangements from the t(2;8)(p15;q24)
Differentially labelled probes RP11-479F13 and RP11-119H15 were used as a first approach of the BCL11A-REL region (Figure 1e) . A split of one of the colocalized signals was observed. Chromosome walking with probes within this region led to the identification of the partially sequenced RP11-440P5 probe as containing the breakpoint (Figures 1e and 2h ).
Genomic breakpoints of the t(8;9)(q24;p13) translocations
In case no. 1, the myc-tel0 probe showed 13.0 and 6.4 kb rearranged fragments after DNA digestion with EcoRI and HindIII, respectively (Figure 3b) . To clone the breakpoint, LDI PCR was carried out on HindIII digests by use of primers 1_RE and 1_FE and nested primers 1_RI and 1_FI. Two 5.4 and 6.5 kb fragments were amplified (Figure 3c ). The 5.4 kb fragment corresponded to a germline chromosome 8 sequence whereas the 6.5 kb fragment contained the breakpoint of the der(9) chromosome. Sequencing results were used to predict the sequence of the der(8) breakpoint and direct PCR was performed with primer pairs 1der8_8/1der8_9 and 1der9_8/1der9_9 to amplify the breakpoints from both derivative chromosomes, generating products of 600 and 550 bp, respectively (Figure 3d ). Sequence analysis showed that the breakpoint was located 7 kb 3 0 from MYC and 15 kb 5 0 from the second exon of the zinc finger and BTB domain containing 5 (ZBTB5) gene on 9p13 (Figure 3e) . A 30 bp deletion on chromosome 8 was observed, along with a 46 bp deletion on chromosome 9. A 18 bp insertion on the der(9) chromosome was observed at the breakpoint. This sequence was the inverted copy of a 18 bp sequence located 600 bp upstream, as revealed by homology search against the sequence of BAC clone RP11-405L18. Sequencing of this region from the der(9) revealed an absence of 18 bp deletion, allowing to conclude that the insertion was probably not due to a transposition.
In case no. 2, 13.7 and 11 kb rearranged fragments were detected from HindIII and BglII digestions respectively by the myc-exon3 probe (Figure 3b) . Analysis of LDI PCR products obtained from the HindIII digestion with primers 2_RE and 2_FE and nested primers 2_RI and 2_FI displayed one 2.0 kb single band containing the der(9) breakpoint (Figure 3c ). The expected 11 kb germline band could not be detected probably due to preferential amplification of the lower size rearranged band. As above, sequencing data were used to predict the sequence of the der(8) breakpoint, and direct PCR was performed with primers 2der8_8/2der8_9 and 2der9_8/2der9_9 to amplify der(8) and .439], respectively. Overall comparison of the three groups performed using the Kruskall-Wallis test showed a significant difference (P ¼ 5.10 À6 ). MYC expression was significantly higher in group (a) than in group (b) (P ¼ 0.006). No significant difference was found between groups (a) and (c) (P ¼ 0.122). When data from groups with 8q24 rearrangement (i.e., groups (a) and (c) were pooled, median value of the resulting group, 2.529 [1.610-4.333] was found to be significantly higher than median value from group (b), that is without 8q24 rearrangement (P ¼ 1.10 À6 ).
Discussion
A recently published series of 87 NHLs patients with 8q24 rearrangements showed that this anomaly, whatever the partner gene, was associated with an unfavourable outcome. 21 In this study, 8q24 rearrangements with non-IG partner were found in 26 patients, none of whom had a Burkitt's lymphoma. Those rearrangements involved mainly non-identified partner regions. However, the Xq22, 3p25, 6q13, 9p13, 9q13 and 2q13 regions were also implicated (once each), as the 8q region itself, which was deleted or duplicated in five patients. These results lead us to undertake the present study, aiming to identify non-IG MYC partners and to analyse the consequences of the translocation. Seventeen samples with non-IG/8q24 translocation and material for cytogenetics and molecular procedures were available from our lymphoma database. FISH was used as a first approach and our results showed that approximate breakpoint locations deduced from the identification of breakpointcontaining probes were highly dispersed around MYC as previously reported for MYC/IG translocations in Burkitt's lymphomas 22, 23 and more recently in myeloma. 15 We further focused our study on 7 cases for which breakpoints were located within 1 Mb from MYC on either side. Those were dispersed over 430 kb, three cases being clearly telomeric to MYC (cases 5-7). In the four remaining cases (cases 1-4) , the probe contained MYC and the breakpoint was located close to the gene, but without any additional information about its orientation relative to MYC.
For these seven patients, the chromosomal region translocated near MYC was 2p15, 3q27, 7p12 or 9p13. As these regions contain genes known to be involved in NHL, we reasoned that this fact was probably non-random and decided to focus our investigations on these particular genes, namely BCL11A, BCL6, IKAROS and PAX5. In every case, we found that the breakpoint was located in the vicinity of these target genes, within distances varying from a few base pairs for BCL11A to one megabase for IKAROS.
In our study, breakpoints of two t(8;9) translocations were cloned. Chromosome 8 breakpoints were found to be located 2 and 7 kb downstream from MYC, in a 10 kb region where eight other breakpoints have been sequenced previously. 6, [24] [25] [26] [27] [28] [29] [30] This clustering could be related to the high density of Alu sequences found in the region, whose involvement in recombination has been suggested, 31 but also to the presence of DNaseI hypersensitivity sites, mapped from 1.9 to 32 kb downstream from MYC. 32 Several breakpoints have been reported on chromosome 9 in the vicinity of those that were identified in our patients. In a t(9;14)(p11;q32), the breakpoint was located 14 kb centromeric to the ZCCHC7 transcriptional unit. 33 In two t(3;9)(q27;p13) involving BCL6, the partner gene was identified as GRHPR, 65 kb centromeric to the same ZCCHC7 gene in one case 34 whereas in the second case explored by FISH, the break was covered by the RP11-405L18 probe which partially contain ZBTB5, PRAF1 and GRHPR as for patient 1 in our study. 35 Breakpoints of the t(3;8)(q27;q24) reflect the heterogeneity of BCL6 translocations previously reported in nodular lymphocyte predominant Hodgkin's lymphoma, 35 as breaks were located close to the MBR region in case no. 6 and rather near the ABR region in case no. 7.
Consequence of a translocation can be the formation of a fusion gene and/or the deregulation of gene expression. Using PCR, we searched fusion transcripts in cases for which MYC and candidate partner genes were in the same transcriptional orientation, and for which breakpoint were in the vicinity of genes, that is in cases no. 1 and no. 4, but results were negative. The seven cases described in this work showed similarities with MYC-IGK or IGL translocations, with breakpoints localized downstream from MYC (in at least five cases) and polydispersed, up to 350 kb from MYC. The consequence is that activation of MYC transcription by a promoter translocated upstream the gene cannot be hypothesized, deregulation being rather mediated by cis-acting enhancer elements provided by translocated sequences, as for MYC-IG light chains translocations. 36, 37 The absence of cryptic insertion of an IGH gene fragment between MYC and the translocated partner, which could be responsible for MYC deregulation, was verified in our patients by use of the LSI IGH/BCL2 FISH probe from Vysis, which contains IGH constant regions and enhancers. The hypothesis of enhancers provided by non-IG translocated sequences was suggested in one case of a t(8;12)(q24;q22). 6 However, MYC deregulation by translocated enhancers may be questionable in cases 6 and 7, with breakpoints localized several hundred kilobases from MYC. This point was discussed in a recent work. 38 As was demonstrated in MYC-IGK translocations, the formation of a loop of the translocation region, bringing together MYC and translocated enhancers elements, with intermediate sequences looped out could be suggested. 39 In the work abovementioned, 6 BTG1, the MYC candidate partner gene of the translocation was also overexpressed, thus suggesting a crossedregulation performed by each translocated sequences. The presence of two enhancer elements 3 0 to MYC 32 support this hypothesis. Whether these translocations are also able to deregulate genes located in MYC partner regions, for example BCL6, BCL11A, IKAROS, PAX5, ZBTB5, ZCCHC7 or COBL, remains to be investigated.
Noteworthy, these 8q24 rearrangements should probably be considered as secondary events, occurring in patients bearing a t(14;18)(q32;q21) in six of seven cases. This was also the case in the series reported by Au et al., 21 in which 8q24 defects involving a non-IG partner mainly affect patients with a primary genetic defect, t(14;18) in follicular lymphoma, Burkitt-like lymphoma or DLBCL, or t(11;14) in mantle cell lymphoma. The association of a t(14;18) and a secondary t(8;14) has been related to the transformation of low to high-grade lymphoma, associated with a poor outcome. 3, 40 In both t(8;9) cases, junctions on both derivative chromosomes were complex, but neither recombination signal sequences nor N-nucleotides addition were found, suggesting that these translocations occurred after the t(14;18), supposed to be the consequence of a mistake in VDJ joining. The presence of insertions and deletions at the breakpoints rather suggests that the translocations could be a by-product of MYC-targeted somatic hypermutations. 41, 42 Recently, two studies defined a gene expression profile which could reliably distinguish Burkitt's lymphoma from DLBCL. 43, 44 Burkitt's lymphoma is mainly distinguished from DLBCL by the high expression level of MYC target genes, the expression of some GCB-related genes and the low expression of HLA-class I and nuclear factor-kB target genes. 43 Furthermore, gene expression profiling distinguished, in most cases, Burkitt's lymphoma from DLBCL with MYC translocation, allowing to define a molecular Burkitt's lymphoma group. 44 In the present study, despite a high level of MYC mRNA expression, involvement of a non-IG partner with MYC, additional complex chromosomal changes, concurrent BCL6/BCL2 translocations, and a non-GCB phenotype are features likely associated to a gene expression profile distinct from the Burkitt's lymphoma molecular signature. In addition, the unfavourable outcome of our cases is consistent with the poor prognosis observed in DLBCL harbouring a translocation involving MYC but without a typical gene signature of Burkitt's lymphoma. 44 This study, representing a first characterization of MYC translocations with non-IG loci in non-Burkitt's B-cell lymphomas, shows that breakpoints involved in these rearrangements are dispersed over several Mb on each side of MYC. In seven cases where the breakpoint was found inside a 2 Mb region encompassing MYC, the partner region contained a gene known to be involved in B-cell lymphoma translocations. As a result of these translocations, MYC RNA levels were high as compared to those of patients without 8q24 rearrangement. Taken together, these results suggest that these secondary events targeting MYC together with partner genes known to be involved in lymphoma genesis are non random and play a key role in lymphoma progression.
